Risk analysis of analytical validations by probabilistic modification of FMEA
Publication: Research - peer-review › Journal article – Annual report year: 2012
Standard
Risk analysis of analytical validations by probabilistic modification of FMEA. / Barends, D.M.; Oldenhof, M.T.; Vredenbregt, M.J.; Nauta, Maarten .
In: Journal of Pharmaceutical and Biomedical Analysis, Vol. 64-65, 2012, p. 82-86.Publication: Research - peer-review › Journal article – Annual report year: 2012
Harvard
APA
CBE
MLA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Risk analysis of analytical validations by probabilistic modification of FMEA
A1 - Barends,D.M.
A1 - Oldenhof,M.T.
A1 - Vredenbregt,M.J.
A1 - Nauta,Maarten
AU - Barends,D.M.
AU - Oldenhof,M.T.
AU - Vredenbregt,M.J.
AU - Nauta,Maarten
PB - Elsevier BV
PY - 2012
Y1 - 2012
N2 - Risk analysis is a valuable addition to validation of an analytical chemistry process, enabling not only detecting technical risks, but also risks related to human failures. Failure Mode and Effect Analysis (FMEA) can be applied, using a categorical risk scoring of the occurrence, detection and severity of failure modes, and calculating the Risk Priority Number (RPN) to select failure modes for correction. We propose a probabilistic modification of FMEA, replacing the categorical scoring of occurrence and detection by their estimated relative frequency and maintaining the categorical scoring of severity. In an example, the results of traditional FMEA of a Near Infrared (NIR) analytical procedure used for the screening of suspected counterfeited tablets are re-interpretated by this probabilistic modification of FMEA. Using this probabilistic modification of FMEA, the frequency of occurrence of undetected failure mode(s) can be estimated quantitatively, for each individual failure mode, for a set of failure modes, and the full analytical procedure.
AB - Risk analysis is a valuable addition to validation of an analytical chemistry process, enabling not only detecting technical risks, but also risks related to human failures. Failure Mode and Effect Analysis (FMEA) can be applied, using a categorical risk scoring of the occurrence, detection and severity of failure modes, and calculating the Risk Priority Number (RPN) to select failure modes for correction. We propose a probabilistic modification of FMEA, replacing the categorical scoring of occurrence and detection by their estimated relative frequency and maintaining the categorical scoring of severity. In an example, the results of traditional FMEA of a Near Infrared (NIR) analytical procedure used for the screening of suspected counterfeited tablets are re-interpretated by this probabilistic modification of FMEA. Using this probabilistic modification of FMEA, the frequency of occurrence of undetected failure mode(s) can be estimated quantitatively, for each individual failure mode, for a set of failure modes, and the full analytical procedure.
KW - Analytical validation
KW - FMEA
KW - Human factor
KW - Risk analysis
KW - NIR
U2 - 10.1016/j.jpba.2012.02.009
DO - 10.1016/j.jpba.2012.02.009
JO - Journal of Pharmaceutical and Biomedical Analysis
JF - Journal of Pharmaceutical and Biomedical Analysis
SN - 0731-7085
VL - 64-65
SP - 82
EP - 86
ER -